Target Name: MID1
NCBI ID: G4281
Review Report on MID1 Target / Biomarker Content of Review Report on MID1 Target / Biomarker
MID1
Other Name(s): OTTHUMP00000022898 | OTTHUMP00000022899 | FXY | RNF59 | tripartite motif protein TRIM18 | Putative transcription factor XPRF | XPRF | Opitz/BBB syndrome | midline 1 RING finger protein | ZNFXY | OSX | GBBB1 | Midin | tripartite motif-containing protein 18 | FLJ57031 | TRIM18 | FLJ58683 | midline 1 | Midline 1, transcript variant 6 | Tripartite motif protein TRIM18 | OTTHUMP00000022896 | RING finger protein Midline-1 | RING-type E3 ubiquitin transferase Midline-1 | E3 ubiquitin-protein ligase Midline-1 | GBBB | Midline 1 RING finger protein | MID1 variant 6 | putative transcription factor XPRF | zinc finger on X and Y, mouse, homolog of | OS | OTTHUMP00000022902 | TRI18_HUMAN | MIDIN | E3 ubiquitin-protein ligase Midline-1 (isoform 1) | Tripartite motif-containing protein 18 | Zinc finger on X and Y, mouse, homolog of | MID1 variant 1 | BBBG1 | OTTHUMP00000022900 | Midline 1, transcript variant 1 | OTTHUMP00000022901 | RING finger protein 59 | FLJ76288 | E3 ubiquitin-protein ligase Midline-1 (isoform 3) | OGS1

OTTHUMP00000022898: A Promising Drug Target for MID1-related Diseases

MID1 (middle income decile one) is a demographic group that represents the largest segment of the global population, making it an attractive target for drug development. MID1 individuals are those who have a moderate income level but are not considered to be high-income individuals. They are the ones who are striving to make a better life for themselves and their families but are often overlooked by the pharmaceutical industry.

Scientists and researchers have been searching for new treatments and drugs that can help improve the health and well-being of MID1 individuals. One promising lead is the drug MID1-targeting small molecule inhibitor OTTHUMP00000022898, which has been shown to have potential in treating various diseases.

OTTHUMP00000022898 is a small molecule inhibitor that targets the MID1 protein, which is a key regulator of the blood-brain barrier. The blood-brain barrier is a barrier that separates the brain from the rest of the body and helps to protect it from harmful substances. However, this barrier can also prevent the delivery of essential medications to the brain.

MID1-targeting small molecule inhibitor OTTHUMP00000022898 has been shown to improve the delivery of oxygen and nutrients to the brain, while also reducing the amount of toxic substances that can enter the brain. This has potential in treating a variety of MID1-related diseases, including neurodegenerative diseases, such as Alzheimer's and Parkinson's, as well as brain injuries and inflammation.

One of the key benefits of OTTHUMP00000022898 is its ability to target the MID1 protein specifically, rather than other proteins that may be involved in the blood-brain barrier. This allows for a more targeted and effective treatment of MID1-related diseases.

In addition to its potential as a drug, OTTHUMP00000022898 also has potential as a biomarker. By measuring the levels of MID1 protein in the brain, researchers can track the effectiveness of the drug and monitor its progress. This could be valuable for identifying potential drug-resistant strains of MID1-related diseases and for developing new treatments.

OTTHUMP00000022898 is also a promising lead for a new type of drug development, known as \"segmental targeting.\" This approach involves developing drugs that specifically target a particular segment of the population, rather than a broad target like all proteins. This can help to reduce the risk of drug interactions and side effects, and can also help to increase the effectiveness of the drug.

With its potential as a drug and biomarker, OTTHUMP00000022898 is an attractive target for drug development. Researchers are currently working to further develop the drug and to determine its safety and effectiveness in treating MID1-related diseases.

In conclusion, OTTHUMP00000022898 is a promising drug target and biomarker for MID1-related diseases. With its ability to target the MID1 protein specifically and its potential as a drug, it has the potential to improve the health and well-being of MID1 individuals. Further research is needed to determine its safety and effectiveness in treating MID1-related diseases.

Protein Name: Midline 1

Functions: Has E3 ubiquitin ligase activity towards IGBP1, promoting its monoubiquitination, which results in deprotection of the catalytic subunit of protein phosphatase PP2A, and its subsequent degradation by polyubiquitination

The "MID1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MID1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MID1IP1 | MID1IP1-AS1 | MID2 | MIDEAS | MIDEAS-AS1 | MIDN | MIEF1 | MIEF2 | MIEN1 | MIER1 | MIER2 | MIER3 | MIF | MIF-AS1 | MIF4GD | MIGA1 | MIGA2 | MIIP | MILIP | MILR1 | MIMT1 | MINAR1 | MINAR2 | MINCR | MINDY1 | MINDY2 | MINDY2-DT | MINDY3 | MINDY4 | Minichromosome maintenance (MCM) 2-7 helicase complex | MINK1 | MINPP1 | MIOS | MIOX | MIP | MIPEP | MIPEPP3 | MIPOL1 | MIR1-1 | MIR1-1HG | MIR1-2 | MIR100 | MIR100HG | MIR101-1 | MIR101-2 | MIR10394 | MIR10396B | MIR10399 | MIR103A1 | MIR103A2 | MIR103B1 | MIR103B2 | MIR105-1 | MIR105-2 | MIR10527 | MIR106A | MIR106B | MIR107 | MIR10A | MIR10B | MIR11181 | MIR11400 | MIR11401 | MIR1178 | MIR1179 | MIR1180 | MIR1181 | MIR1182 | MIR1183 | MIR1184-1 | MIR1184-2 | MIR1184-3 | MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236